Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
MRL Ventures Fund
AddedFeb 13, 2024
UpdatedJun 28, 2026
MRL Ventures Fund

MRL Ventures Fund

Operating

MRLV, a Cambridge-based VC fund, invests globally in innovative firms developing transformative medicines.

Location
Cambridge, MA, US
Founded
2014
Firm
Compare
Portfolio
Fundraising
Employees

MRL Ventures Fund (MRLV) invests in innovative therapeutics companies that are developing transformative medicines that have the potential to meaningfully improve the lives of patients.

MRLV is based in Cambridge, MA and is actively seeking investment opportunities globally.

MRL Ventures Fund - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments24
Current Portfolio Count14
Total Portfolio Exits0

Top Investment Stages

Series A10 (43.5%)
Series B7 (30.4%)
Series C4 (17.4%)
Seed1 (4.3%)
Series D1 (4.3%)

Stage Mix

Series A 43%Series B 30%Series C 17%Seed 4%Series D 4%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Therini Bio logo

Therini Bio

Carisma Therapeutics logo

Carisma Therapeutics

Photys Therapeutics logo

Photys Therapeutics

Aktis Oncology logo

Aktis Oncology

LifeMine Therapeutics logo

LifeMine Therapeutics

Ambagon Therapeutics logo

Ambagon Therapeutics

Mozart Therapeutics logo

Mozart Therapeutics

PAQ Therapeutics logo

PAQ Therapeutics

Entrada Therapeutics logo

Entrada Therapeutics

Tallac Therapeutics logo

Tallac Therapeutics

HotSpot Therapeutics logo

HotSpot Therapeutics

Kymera Therapeutics logo

Kymera Therapeutics

Alector logo

Alector

Spero Therapeutics logo

Spero Therapeutics

MRL Ventures Fund - Similar Investment Firms

Inbio Ventures logo

Inbio Ventures

Mblvc logo

Mblvc

Morgenthaler logo

Morgenthaler

M Ventures logo

M Ventures

Healthcare Ventures logo

Healthcare Ventures

hcven.com

Common Sense Ventures logo

Common Sense Ventures

BioInnovation logo

BioInnovation

Milamber Ventures logo

Milamber Ventures

Multiverse Investments logo

Multiverse Investments

LiquidMetal Ventures logo

LiquidMetal Ventures

liquidmetalvc.com

Pathway to Cures logo

Pathway to Cures

pathwaytocures.org

Merlin Ventures logo

Merlin Ventures

merlin.vc

Merrill Lynch Ventures logo

Merrill Lynch Ventures

R3 Venture Partners logo

R3 Venture Partners

Chiesi Ventures logo

Chiesi Ventures

chiesiventures.com

MRL Ventures Fund - Classification

Also Known As
  • MRL Ventures Fund LLC
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end
Show 2 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
SIC
  • 6000Depository Institutions